Related Experiment Videos
[Unknown fixed cutaneous sporotrichosis]
Luis Javier Méndez Tovar1, Adriana E Anides-Fonseca, Gonzálo Peña-González
1Unidad de Investigación Médica en Dermatología y Micología, Dr. Ernesto Macotela Ruíz, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, IMSS, Mexico. ljmt@servidor.unam.mx
Revista Iberoamericana De Micologia
|February 16, 2005
Summary
Sporotrichosis, a common fungal infection in Mexico, can present atypically. This case highlights a rare form of fixed cutaneous sporotrichosis incognito, successfully treated with itraconazole.
Area of Science:
- Mycology
- Dermatology
- Infectious Diseases
Background:
- Sporotrichosis is the most prevalent subcutaneous mycosis in Mexico.
- Common clinical presentations include lymphocutaneous and fixed cutaneous forms.
Observation:
- A male patient presented with an erythematous plaque exhibiting radial growth.
- Initial empirical therapy and topical steroids altered the clinical presentation to vesicles, ulcers, and crusts.
Findings:
- Diagnosis of fixed cutaneous sporotrichosis incognito was confirmed via clinical, mycological, and histopathological evaluation.
- In vitro and in vivo delayed cellular immunity tests were within normal limits.
- The patient achieved complete clinical and mycological recovery after four months of oral itraconazole treatment.
Implications:
- This case underscores the importance of considering atypical presentations of sporotrichosis, even with normal immune function.
- It highlights the efficacy of oral itraconazole in treating challenging cases of fixed cutaneous sporotrichosis incognito.
- Accurate diagnosis and timely treatment are crucial for managing this neglected tropical disease.